References
- Pestieau S, Esquivel J, Sugarbaker P. (2000). Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol 7:199–203.
- Dang A, Mansfield P, Ilsin B, et al. (2007). Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei. J Cardiothorac Vasc Anesth 21:265–8.
- Kerscher C, Ried M, Hofmann HS, et al. (2014). Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion. J Cardiothorac Surg 9:125–33.
- Lord AC, Shibab O, Chandrakumaran K, et al. (2015). Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Europ J Surg Oncol 41:396–9.
- Ghosh RK, Somasundaram M, Ravakhah K, Hassan C. (2016). Pseudomyxoma peritonei with intrathoracic extension: a rare disease with rarer presentation from low-grade mucinous adenocarcinoma of the appendix. BMJ Case Rep. doi: 10.1136/bcr-2015-211076
- Thanigaimani K, Mohamed F, Cecil T, et al. (2013). The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. Colorectal Dis 15:1537–42.
- Sugarbaker PH. (2007). Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia 23:431–42.
- Ried M, Potzger T, Braune N, et al. (2013). Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience. Eur J Cardiothorac Surg 43:801–7.
- Benes JM, Gliglio M, Brienza N, Michard F. (2014). The effects of goal-directed fluid therapy based on dynamic parameters on post-surgical outcome: a meta-analysis of randomized controlled trials. Crit Care 18:584–95.
- Doyle MP, Villanueva CI, Davies S, et al. (2016). Cytoreductive surgery and heated intrathoracic chemotherapy for thoracic extension of Pseudomyxoma peritonei. Integr Cancer Sci Therap 3:504–8.
- Brandstrup B, Tonnesen H, Beier-Holgersen R, et al. (2003). Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 238:641–8.
- Chen MY, Chiles C, Loggie BW, et al. (1997). Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol 66:19–23.
- Zappa L, Savady R, Humphries GN, Sugarbaker P. (2009). Interstitial pneumonitis following intrapleural chemotherapy. World J Surg Oncol 7:17. doi: 10.1186/1477-7819-7-17
- Van Ruth S, Baas P, Haas RLM, et al. (2003). Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma. Ann Surg Onc 10:176–82.
- Hakeam HA, Breakiet M, Azzam A, et al. (2014). The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail 36:1486–91.